Terms: = Ovarian cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
9 results:
1. Cyclotheonellazoles D-I, Potent Elastase Inhibitory Thiazole-Containing Cyclic Peptides from
Holland DC; Schroder WA; Calcott MJ; Kaemmerer E; Avery VM; Ekins MG; Carroll AR
J Nat Prod; 2023 Sep; 86(9):2216-2227. PubMed ID: 37609780
[TBL] [Abstract] [Full Text] [Related]
2. Your Family Connects: A Theory-Based Intervention to Encourage Communication about Possible Inherited cancer Risk among ovarian cancer Survivors and Close Relatives.
Zhao J; McBride CM; Campbell GP; Pentz RD; Escoffery C; Konomos M; Bellcross C; Ward K; Shepperd JR; Guan Y
Public Health Genomics; 2023; 26(1):77-89. PubMed ID: 37487468
[TBL] [Abstract] [Full Text] [Related]
3. The importance of the Peritoneal cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Rawert FL; Luengas-Würzinger V; Claßen-Gräfin von Spee S; Baransi S; Schuler E; Carrizo K; Dizdar A; Mallmann P; Lampe B
Arch Gynecol Obstet; 2022 Nov; 306(5):1665-1672. PubMed ID: 35357582
[TBL] [Abstract] [Full Text] [Related]
4. Useful aspects of diagnosis of imprint cytology in intraoperative consultation of ovarian tumors: comparison between imprint cytology and frozen sections.
Azami S; Aoki Y; Iino M; Sakaguchi A; Ogura K; Ogishima D; Matsumoto T
Diagn Cytopathol; 2018 Jan; 46(1):28-34. PubMed ID: 29034605
[TBL] [Abstract] [Full Text] [Related]
5. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract] [Full Text] [Related]
6. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
[TBL] [Abstract] [Full Text] [Related]
7. [CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction].
Gasowska-Bodnar A; Bodnar L; Wcisło GB; Jerzak MM; Szczylik C; Baranowski W
Ginekol Pol; 2008 Feb; 79(2):108-14. PubMed ID: 18510089
[TBL] [Abstract] [Full Text] [Related]
8. Clinical study of multi-drug resistance gene (MDR1) expression in primary ovarian cancer.
Wang S; Cai G
J Tongji Med Univ; 1998; 18(1):58-60. PubMed ID: 10806806
[TBL] [Abstract] [Full Text] [Related]
9. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors.
Tropé C; Kaern J; Vergote IB; Kristensen G; Abeler V
Gynecol Oncol; 1993 Nov; 51(2):236-43. PubMed ID: 8276300
[TBL] [Abstract] [Full Text] [Related]
